Incyte reports 71% response rate for INCA33890 combination in Phase 1 colorectal cancer trial

Bitget2026/10/26 13:46

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Incyte presented early-stage results for cancer treatments INCB161734 and INCA33890 at the ESMO Congress 2026.
INCB161734 combinations showed durable responses in pancreatic cancer and antitumor activity in previously treated colorectal cancer, with manageable safety.
INCA33890 with standard therapies showed preliminary activity across microsatellite-stable colorectal cancer patient groups, with manageable safety.
Phase 3 pancreatic cancer results for INCB161734 are expected in 2028; its colorectal cancer trial should begin in the first half of 2027.
The ongoing Phase 3 trial of INCA33890 with chemotherapy and bevacizumab in first-line microsatellite-stable colorectal cancer expects results in 2029.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Incyte Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261026987057) on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs Volatility Panic Index surged to 9.57, approaching its maximum value, with the largest single-day increase ranking third in history, and the combined two-day volatility setting a new record. Historical data shows that after this index has exceeded the 9.5 threshold 15 times, the S&P 500 has seen an average three-month gain of 4.6% with a success rate of 80%. However, Goldman Sachs traders warn that forced liquidations have not yet fully cleared, and the market is still searching for a bottom, but opportunities on the other side are becoming increasingly difficult to ignore.

华尔街见闻•2026/11/07 07:31

Signal of a rebound? Goldman Sachs US stock panic index reaches "extreme levels"

SpaceX (SPCX.US) undergoes board changes: Google executive departs, Tesla merger evaluation underway.

SpaceX (SPCX.US) announced on Friday that Don Harrison has resigned from the company's board of directors.

智通财经•2026/11/07 06:31

The major cycle's downward structure remains intact, while the minor cycle's rebound lacks volume: Is this a support zone or just a consolidation phase?

AiCoin•2026/11/07 06:03